PLAAT3 and pancreatic neoplasm: As depicted in Figs. 1C–1E, the mutation frequency of PLA2G16 in pancreatic cancer appears relatively low, at 0.3%, with amplification identified as the most prevalent genetic alteration, followed by deep deletion.